TABLE 3.
Intracellular PK parameters of 3TC-TP and TFV-DP in men and women in the presence of lopinavir-ritonavir or nevirapine
Drug | No. of patients | AUC0-4
|
Ctrough
|
||
---|---|---|---|---|---|
Mean (fmol·h/106 cells) | CVa (%) | Mean (fmol/106 cells) | CV (%) | ||
3TC-TP | |||||
With LPV/r | |||||
In women | 2 | 86,710 | 67 | 15,310 | 36 |
In men | 5 | 43,160 | 49 | 9,112 | 12 |
GMRb | 1.91 | 1.64 | |||
With NVP | |||||
In women | 3 | 61,520 | 79 | 14,010 | 86 |
In men | 5 | 38,330 | 43 | 8,185 | 32 |
GMR | 1.40 | 1.42 | |||
P valuec | 0.084 | 0.082 | |||
TFV-DP | |||||
With LPV/r | |||||
In women | 4 | 1,745 | 78 | 315 | 35 |
In men | 10 | 921.2 | 45 | 233.1 | 54 |
GMR | 1.72 | 1.45 | |||
With NVP | |||||
In women | 3 | 829.3 | 30 | 241.5 | 28 |
In men | 10 | 590.8 | 27 | 137.7 | 36 |
GMR | 1.41 | 1.84 | |||
P valuec | 0.045 | 0.039 |
CV, coefficient of variation.
GMR, ratio of the GM for women to the GM for men.
By two-way analysis of variance.